Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Core 60/40 Balanced Allocation ETF (NY:AOR)

66.75 +0.34 (+0.51%)
Official Closing Price Updated: 4:10 PM EST, Jan 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Core 60/40 Balanced Allocation ETF

< Previous 1 2 Next >
News headline image
Why IREN and Cipher Mining Shares Rallied Today? ↗
Anthropic is set to reportedly raise about $20 billion from venture capitalists and other investors, double the amount it had targeted, in a sign of surging investor enthusiasm in the AI space. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
What’s Driving The Sell-Off In Qorvo Shares? ↗
The company said its March quarterly outlook reflects the seasonal decline at its largest customer. 
Via Stocktwits
The Trade Desk Stock Is Again Falling Today – Why Are Analysts Slashing Price Targets? ↗
Via Stocktwits
News headline image
The Trade Desk Shares Are Plunging Today – Another CFO Departs ↗
The Trade Desk said it has appointed Tahnil Davis as interim Chief Financial Officer, after Alex Kayyal stepped down. 
Via Stocktwits
News headline image
CSX Jump More Than 3% After Hours Despite Earnings Miss - Here’s Why ↗
CSX said it expects low single-digit revenue growth in FY26, assuming modest economic momentum and stable fuel and global benchmark coal prices. 
Via Stocktwits
Topics Earnings
Blackstone Shares Dive 5% As It Reportedly Weighs $5B-Plus Sale of Beacon Offshore ↗
Via Stocktwits
Why Are State Street Shares Falling Today? ↗
Via Stocktwits
KKR Shares Rise – What’s With $15B UK Offshore Wind Project? ↗
Via Stocktwits
Boeing Stock Rallies As FY25 Deliveries Jump 435%, Beating Growth At Rival Airbus ↗
Via Stocktwits
News headline image
Capital One Shares Plunges - What’s With $425M Settlement? ↗
federal judge preliminarily approved the company's revised $425 million to settle a lawsuit related to its 360 ‌ Savings accounts with depositors who said they were cheated out of high interest rates. 
Via Stocktwits
Topics Credit Cards Government Lawsuit
News headline image
KKR Stock Rises After Reportedly Quadrupling Its Money On OneStream Bet ↗
According to a report from Bloomberg News, KKR now expects to post a gross internal rate of return of 24.9% based on its initial investment in the company in 2019. 
Via Stocktwits
Boeing’s CEO Tells Staff ‘Important Work Ahead’ To Continue Its Turnaround: Report ↗
Via Stocktwits
Jefferies' Randy Konik Sees Nike Getting 'Its Act Together' Under CEO Elliott Hill ↗
Via Stocktwits
Nike Turnaround Faces A Longer Road Despite Brand Strength, UBS Says ↗
Via Stocktwits
Why Did INSP Stock Soar 29% Today? ↗
Via Stocktwits
Uber Delivers Solid Earnings, But Tepid Q4 Guidance Sends Stock Lower ↗
Via Stocktwits
Ford CEO Jim Farley Reportedly Expects US EV Demand To Decline Sharply – Here’s Why ↗
Via Stocktwits
Acadia Healthcare Stock Surges Pre-Market After Activist Hedge Fund Reportedly Seeks Board Revamp ↗
Via Stocktwits
News headline image
Lumentum Stock On Track To Record 8th Consecutive Monthly Gain – What’s Making Analysts So Bullish? ↗
The stock hit a record high on Wednesday, helped by positive commentary from top analysts and strong revenue expectations for the current quarter. 
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
Ford Tops US Auto Recall List In 2025 With 150 Recalls, Stellantis Trails—Tesla Ranks Far Lower ↗
Ford issued 150 recalls in the U.S. this year while GM issued 27 and Stellantis, 53. 
Via Stocktwits
Topics Earnings Product Recall
News headline image
CACI International To Acquire ARKA From Blackstone Funds In $2.6B Cash Deal ↗
ARKA Group offers space-based sensor technology and optical technology that will enable CACI to expand its offerings 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Why Did Coty Offload Wella From Its Portfolio? ↗
Coty has sold its remaining 25.8% stake in Wella to KKR-managed capital accounts and investment affiliates for an upfront cash payment of $775 million. 
Via Stocktwits
Topics Economy Initial Public Offering
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study ↗
Via Stocktwits
BWXT Shares Climb On Department Of Energy’s $1.5B Contract ↗
Via Stocktwits
News headline image
Sarepta Wins FDA Approval To Begin Study On Reducing Liver Injury Risk With Elevidys ↗
The data from the study cohort will be used to determine whether administering sirolimus before and after the ELEVIDYS infusion can help reduce acute liver injury, the company said. 
Via Stocktwits
News headline image
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates ↗
The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027. 
Via Stocktwits
Topics Artificial Intelligence World Trade
News headline image
American Airlines Names Aviation Veteran Nathaniel Pieper As Chief Commercial Officer ↗
American Airlines said that Pieper joins the company after serving as oneworld CEO since April 2024. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm ↗
BofA analyst Alexander Perry raised the firm's price target on Polaris to $70 from $60 after the company agreed to sell a majority stake in Indian Motorcycle to California-headquartered private equity... 
Via Stocktwits
News headline image
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study ↗
The company said on Wednesday that its drug did not meet the primary endpoint of the trial primarily due to a higher-than-expected placebo response rate. 
Via Stocktwits
News headline image
Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study ↗
The company noted that the safety and tolerability of intranasal Carbetocin were consistent with those observed in previous clinical trials. 
Via Stocktwits
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.